Penn Medicine Heart and Vascular Center
Who Is Appropriate for PCSK-9 Inhibitors, Including Inclisiran?
By
Penn Medicine Heart and Vascular Center
FEATURING
Archna Bajaj
By
Penn Medicine Heart and Vascular Center
FEATURING
Archna Bajaj
Login to view comments.
Click here to Login
Hypertension, Lipids, and Approaches to CV Pharmacologic Risk Reduction 2023